BSE 741.85 NSE 742.00

indian flag icon

India

USA

great-britain flag icon

UK

south-africa flag icon

South Africa

australia flag icon

Australia

philippines flag icon

Philippines

germany flag icon

Germany

netherlands flag icon

Netherlands

mexico flag icon

Mexico

brazil flag icon

Brazil

BSE 741.85 NSE 742.00

Investors

What's New

Lupin Launches LYFE, its Digital Therapeutic Solution for Holistic Heart Care

Press Release

January 24, 2023

Lupin Launches Sacubitril and Valsartan Combination Drug for Heart Failure Patients

Press Release

January 18, 2023

Lupin Receives Tentative Approval from U.S. FDA for Dolutegravir and Rilpivirine Tablets

Press Release

January 16, 2023

Lupin and Exeltis Announce Reimbursement Approval of NaMuscla® in Spain for the Symptomatic Treatment of Myotonia in Adults with non-dystrophic myotonic (NDM) Disorders

Press Release

January 9, 2023

Lupin Receives Approval from U.S. FDA for Fesoterodine Fumarate Extended-Release Tablets

Press Release

January 6, 2023

Lupin Launches novel fixed-dose triple drug combination DIFIZMA® DPI to Treat Inadequately Controlled Asthma

Press Release

January 5, 2023

Lupin Diagnostics Expands its Footprint in Central India; Launches Regional Reference Laboratory in Indore

Press Release

December 21, 2022

Lupin Receives Approval from U.S. FDA for Brivaracetam Tablets

Press Release

December 21, 2022

Lupin Launches Authorized Generic Version of PENNSAID® 2% w/w in the United States

Press Release

December 9, 2022

Lupin Appoints Spiro Gavaris as President of U.S. Generics Business

Press Release

December 8, 2022

Lupin Launches Rufinamide Tablets USP in the United States

Press Release

December 5, 2022

Lupin Launches Formoterol Fumarate Inhalation Solution in the United States

Press Release

November 29, 2022

Lupin’s Brazilian Subsidiary, MedQuimica Acquires Rights to Nine Brands from Bausch Health

Press Release

November 28, 2022

Lupin Signs MoU with the Government of Rajasthan to strengthen Healthcare system

Press Release

November 21, 2022

Luforbec® 200/6 (beclometasone 200mcg / formoterol 6mcg) a certified carbon neutral inhaler is launched in the UK for the treatment of adult asthma1,2,3

Press Release

November 14, 2022

Lupin Q2 FY2023 Results

Press Release

November 9, 2022

Lupin Receives Tentative Approval from U.S. FDA for Drospirenone Tablets

Press Release

November 4, 2022

Lupin Launches Paliperidone Extended-Release Tablets in the United States

Press Release

October 20, 2022

Lupin Signs Agreement to Acquire Two Inhalation Brands from Sunovion

Press Release

October 20, 2022

Lupin Partners with Global Agencies to Increase Patient Access to Tuberculosis Prevention Treatment

Press Release

October 7, 2022

Lupin Appoints Dr. Shahin Fesharaki as Global Chief Scientific Officer

Press Release

October 7, 2022

Lupin Receives Approval from U.S. FDA for Darunavir Tablets

Press Release

October 4, 2022

Lupin Life announces association with Vikram Vedha as official energy partner with its Be One health and wellness supplement

Press Release

October 1, 2022

Lupin gets EIR from US FDA for its Ankleshwar Manufacturing Facility

Press Release

October 1, 2022

Lupin Receives Approval from U.S. FDA for Mirabegron Extended-Release Tablets

Press Release

September 29, 2022

Lupin Launches Sildenafil for Oral Suspension in the United States

Press Release

September 29, 2022

Lupin Receives Approval from U.S. FDA for Diclofenac Sodium Topical Solution USP, 2% w/w

Press Release

September 22, 2022

Lupin Receives Tentative Approval from U.S. FDA for Dolutegravir, Emtricitabine and Tenofovir Alafenamide (DETAF) Tablets

Press Release

January 31, 2023

Reports & Filings

Integrated Report 2022

Visit Microsite Download Now View all

Q2 FY 2023

Gross Profit : INR 23,784 mn
Gross profit margin : 58.1%
Investment in R&D : INR 3,376 mn

Download Results View all Results

Exchange filings (BSE/NSE)

Corporate Governance

Committees of the Board

Code of Conduct

<span data-mce-type="bookmark" style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" class="mce_SELRES_start"></span><span data-mce-type="bookmark" style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" class="mce_SELRES_start"></span><span data-mce-type="bookmark" style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" class="mce_SELRES_start"></span><span data-mce-type="bookmark" style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" class="mce_SELRES_start"></span>

Shareholder Information

News and Events

Press Release

Lupin Quarter I FY2023 Results

Annual General Meeting

The 40th Annual General Meeting to be held on 3^rd August 2022 at 4 pm through Video Conferencing

Investor Contacts

Shareholder Services

investorservices@lupin.com
Investor Relations

hemantpunamiya@lupin.com

Search

Hit enter to search or ESC to close

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
ARRAffinity	6 months	This cookie is set by websites that run on Windows Azure cloud platform. The cookie is used to affinitize a client to an instance of an Azure Web App.
cookielawinfo-checkbox-advertisement	6 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertisement".
cookielawinfo-checkbox-analytics	6 months	These cookies are set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-functional	6 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	6 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	6 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Other".
cookielawinfo-checkbox-performance	6 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	6 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.

Cookie	Duration	Description
lang	1 year	This cookie is used to store the language preferences of a user to serve up content in that stored language the next time user visit the website.

Performance

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

Cookie	Duration	Description
YSC	1 session	This cookies is set by YouTube and is used to track the views of embedded videos and captures the number of views and is relevant to only one session

Analytics

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.

Cookie	Duration	Description
_ga	1 years	This cookie is installed by Google Analytics. The cookie is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. The cookies store information anonymously and assign a randomly generated number to identify unique visitors.
_gat_gtag_UA_139647988_1	1 minute	These cookies are set by Google Analytics which is a simple tool that helps us measure how users interact with our website. As a user navigates between web pages, Google Analytics records information about the page a user has visited, for example the URL of the page. The cookies themselves are used to 'remember' what a user has done on previous pages and interactions with our website.
_gid	1 day	This cookie is installed by Google Analytics. The cookie is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.

Advertisement

Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.

Cookie	Duration	Description
IDE	1 year	Used by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
test_cookie	15 minutes	This cookie is set by doubleclick.net. The purpose of the cookie is to determine if the user's browser supports cookies.
VISITOR_INFO1_LIVE	5 months 27 days	This cookie is set by Youtube. Used to track the information of the embedded YouTube videos on a website.

Others

Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.

Cookie	Duration	Description
ARRAffinitySameSite	session	No description
CONSENT	6 months	No description